Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer

Inflammation

Volumn 38, Issue 6, 2015, Pages 2156-2165

  Duan, Min Chao ^a   Han, Wei ^a   Jin, Pei Wen ^a   Wei, Yu Ping ^a   Wei, Qiu ^b   Zhang, Liang Ming ^b   Li, Jun Chen ^a  

^a The Eighth People s Hospital of Nanning   (China)

^b First People's Hospital of Nanning   (China)

Author keywords

cytokine; differentiation; imbalance; non small cell lung cancer; Th17 cell; treg cell

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NON SMALL CELL LUNG CANCER; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH17 CELL; TISSUE SECTION; UPREGULATION; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CELL SEPARATION; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; TUMOR MICROENVIRONMENT;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CELL SEPARATION; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TUMOR MICROENVIRONMENT;

EID: 84946474062     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0198-x     Document Type: Article

References (35)

1. Jemal, A., F. Bray, M.M. Center, et al. 2011. Global cancer statistics. CA: a Cancer Journal for Clinicians 2: 69–90.
2. Imahayashi, S., T. So, M. Sugaya, et al. 2002. Establishment of an immortalized T-cell line from lung cancer tissue: phenotypic and functional analyses. International Journal of Clinical Oncology 7: 38–44.
3. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787–793.
4. Weaver, C.T., and R.D. Hatton. 2009. Interplay between the TH17 and Treg cell lineages: a (co-) evolutionary perspective. Nature Reviews. Immunology 9: 883–889.
5. Ito, N., H. Nakamura, Y. Tanaka, et al. 1999. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer 85: 2359–2367.
6. Bettelli, E., T. Korn, and V.K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Current Opinion in Immunology 19: 652–657.
7. Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nature Medicine 13: 139–145.
8. Korn, T., E. Bettelli, M. Oukka, et al. 2009. IL-17 and Th17 Cells. Annual Review of Immunology 27: 485–517.
9. Bettelli, E., Y. Carrier, W. Gao, et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.
10. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nature Reviews. Immunology 8: 337–348.
11. Zúñiga, L.A., R. Jain, C. Haines, et al. 2013. Th17 cell development: from the cradle to the grave. Immunological Reviews 252: 78–88.
12. Ivanov, I.I., B.S. McKenzie, L. Zhou, et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121–1133.
13. Ohkura, N., Y. Kitagawa, and S. Sakaguchi. 2013. Development and maintenance of regulatory T cells. Immunity 38: 414–423.
14. Whiteside, T. L. 2013. Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer Immunol Immunother. [Epub ahead of print]
15. Koenen, H.J., R.L. Smeets, P.M. Vink, et al. 2008. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340–2352.
16. Koyama, K., H. Kagamu, S. Miura, et al. 2008. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage. Clinical Cancer Research 14: 6770–6779.
17. Ye, Z.J., Q. Zhou, Y.Y. Gu, et al. 2010. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. Journal of Immunology 185: 6348–6354.
18. Li, R., D. Rüttinger, R. Li, et al. 2003. Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer. Langenbeck's Archives of Surgery 388: 406–412.
19. Li, Y., Z.Y. Cao, B. Sun, et al. 2011. Effects of IL-17A on the occurrence of lung adenocarcinoma. Cancer Biology & Therapy 12: 610–616.
20. Numasaki, M., M. Watanabe, T. Suzuki, et al. 2005. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. Journal of Immunology 175: 6177–6189.
21. Li, Q., Y. Han, G. Fei, Z. Guo, T. Ren, and Z. Liu. 2012. IL-17 promoted metastasis of non-small-cell lung cancer cells. Immunology Letters 148: 144–150.
22. Kryczek, I., S. Wei, W. Szeliga, L. Vatan, and W. Zou. 2009. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114: 357–359.
23. Smyth, M.J., M.W. Teng, J. Swann, et al. 2006. CD4+ CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. Journal of Immunology 176: 1582–1587.
24. Zhuo, C., Xu, Y., Ying, M., et al. 2015. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Immunologic Research. Jan 22. [Epub ahead of print]
25. Shimizu, K., M. Nakata, Y. Hirami, et al. 2010. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. Journal of Thoracic Oncology 5: 585–590.
26. Lv, M., Y. Xu, R. Tang, et al. 2014. miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer. Molecular Cancer Therapeutics 13: 3152–3162.
27. Erfani, N., S.M. Mehrabadi, M.A. Ghayumi, et al. 2012. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer 77: 306–311.
28. de Visser, K.E., and W.M. Kast. 1999. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 13: 1188–1199.
29. Salomon, B., D.J. Lenschow, L. Rhee, et al. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431–440.
30. Chen, W., W. Jin, and S.M. Wahl. 1998. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. The Journal of Experimental Medicine 188: 1849–1857.
31. Son, H.J., J. Lee, S.Y. Lee, et al. 2014. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis. Mediators of Inflammation 2014: 973986.
32. Talaat, R.M., S.F. Mohamed, I.H. Bassyouni, et al. 2015. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 72: 146–153.
33. Maggio, R., C. Viscomi, P. Andreozzi, et al. 2014. Normocaloric low cholesterol diet modulates th17/treg balance in patients with chronic hepatitis C virus infection. PloS One 9: e112346.
34. Chang, S.H., S.G. Mirabolfathinejad, H. Katta, et al. 2014. T helper 17 cells play a critical pathogenic role in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 111: 5664–5669.
35. Beriou, G., M. Elizabeth, Bradshaw, et al. 2010. TGF-β induces IL-9 production from human Th17 cells. Journal of Immunology 185: 46–54.